Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

An investigation into the potential role of brain angiogenesis inhibitor protein 3 (BAI3) in the tumorigenesis of small-cell carcinoma: a review of the surrounding literature.

Thomas M, Snead D, Mitchell D.

J Recept Signal Transduct Res. 2017 Aug;37(4):325-334. doi: 10.1080/10799893.2017.1328441. Epub 2017 May 24. Review.

PMID:
28537194
2.

BAI3, CDX2 and VIL1: a panel of three antibodies to distinguish small cell from large cell neuroendocrine lung carcinomas.

Bari MF, Brown H, Nicholson AG, Kerr KM, Gosney JR, Wallace WA, Soomro I, Muller S, Peat D, Moore JD, Ward LA, Freidin MB, Lim E, Vatish M, Snead DR.

Histopathology. 2014 Mar;64(4):547-56. doi: 10.1111/his.12278. Epub 2013 Nov 25.

PMID:
24266897
3.

The small cell lung cancer-specific isoform of RE1-silencing transcription factor (REST) is regulated by neural-specific Ser/Arg repeat-related protein of 100 kDa (nSR100).

Shimojo M, Shudo Y, Ikeda M, Kobashi T, Ito S.

Mol Cancer Res. 2013 Oct;11(10):1258-68. doi: 10.1158/1541-7786.MCR-13-0269. Epub 2013 Aug 8.

4.

The adhesion-GPCR BAI3, a gene linked to psychiatric disorders, regulates dendrite morphogenesis in neurons.

Lanoue V, Usardi A, Sigoillot SM, Talleur M, Iyer K, Mariani J, Isope P, Vodjdani G, Heintz N, Selimi F.

Mol Psychiatry. 2013 Aug;18(8):943-50. doi: 10.1038/mp.2013.46. Epub 2013 Apr 30.

5.

Expression of brain-specific angiogenesis inhibitor 3 (BAI3) in normal brain and implications for BAI3 in ischemia-induced brain angiogenesis and malignant glioma.

Kee HJ, Ahn KY, Choi KC, Won Song J, Heo T, Jung S, Kim JK, Bae CS, Kim KK.

FEBS Lett. 2004 Jul 2;569(1-3):307-16.

6.

G-protein coupled receptor BAI3 promotes myoblast fusion in vertebrates.

Hamoud N, Tran V, Croteau LP, Kania A, Côté JF.

Proc Natl Acad Sci U S A. 2014 Mar 11;111(10):3745-50. doi: 10.1073/pnas.1313886111. Epub 2014 Feb 24.

7.

EPHA3 regulates the multidrug resistance of small cell lung cancer via the PI3K/BMX/STAT3 signaling pathway.

Peng J, Wang Q, Liu H, Ye M, Wu X, Guo L.

Tumour Biol. 2016 Sep;37(9):11959-11971. Epub 2016 Apr 21.

8.

MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs.

Du L, Schageman JJ, Irnov, Girard L, Hammond SM, Minna JD, Gazdar AF, Pertsemlidis A.

J Exp Clin Cancer Res. 2010 Jun 17;29:75. doi: 10.1186/1756-9966-29-75.

9.

Identification of deregulation of apoptosis and cell cycle in neuroendocrine tumors of the lung via NanoString nCounter expression analysis.

Walter RF, Werner R, Ting S, Vollbrecht C, Theegarten D, Christoph DC, Schmid KW, Wohlschlaeger J, Mairinger FD.

Oncotarget. 2015 Sep 22;6(28):24690-8. doi: 10.18632/oncotarget.3992.

10.

Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: a comparative analysis with adenocarcinoma and squamous cell carcinoma.

Matsumura Y, Umemura S, Ishii G, Tsuta K, Matsumoto S, Aokage K, Hishida T, Yoshida J, Ohe Y, Suzuki H, Ochiai A, Goto K, Nagai K, Tsuchihara K.

J Cancer Res Clin Oncol. 2015 Dec;141(12):2159-70. doi: 10.1007/s00432-015-1989-z. Epub 2015 May 20.

11.

RET mutation and expression in small-cell lung cancer.

Dabir S, Babakoohi S, Kluge A, Morrow JJ, Kresak A, Yang M, MacPherson D, Wildey G, Dowlati A.

J Thorac Oncol. 2014 Sep;9(9):1316-23. doi: 10.1097/JTO.0000000000000234.

12.

Evaluation of role of Notch3 signaling pathway in human lung cancer cells.

Hassan WA, Yoshida R, Kudoh S, Motooka Y, Ito T.

J Cancer Res Clin Oncol. 2016 May;142(5):981-93. doi: 10.1007/s00432-016-2117-4. Epub 2016 Feb 2.

PMID:
26838758
13.
14.

The DNA methylation landscape of small cell lung cancer suggests a differentiation defect of neuroendocrine cells.

Kalari S, Jung M, Kernstine KH, Takahashi T, Pfeifer GP.

Oncogene. 2013 Jul 25;32(30):3559-68. doi: 10.1038/onc.2012.362. Epub 2012 Aug 20.

15.

Cloning and characterization of BAI2 and BAI3, novel genes homologous to brain-specific angiogenesis inhibitor 1 (BAI1).

Shiratsuchi T, Nishimori H, Ichise H, Nakamura Y, Tokino T.

Cytogenet Cell Genet. 1997;79(1-2):103-8.

PMID:
9533023
16.

Clinical correlation of extensive-stage small-cell lung cancer genomics.

Dowlati A, Lipka MB, McColl K, Dabir S, Behtaj M, Kresak A, Miron A, Yang M, Sharma N, Fu P, Wildey G.

Ann Oncol. 2016 Apr;27(4):642-7. doi: 10.1093/annonc/mdw005. Epub 2016 Jan 22.

17.

The balance between the expressions of hASH1 and HES1 differs between large cell neuroendocrine carcinoma and small cell carcinoma of the lung.

Nasgashio R, Sato Y, Matsumoto T, Kageyama T, Hattori M, Iyoda A, Satoh Y, Ryuge S, Masuda N, Jiang SX, Saegusa M.

Lung Cancer. 2011 Dec;74(3):405-10. doi: 10.1016/j.lungcan.2011.04.012. Epub 2011 May 20.

PMID:
21601304
18.

Involvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced by HPV E6/E7 oncoproteins.

Buonomo T, Carraresi L, Rossini M, Martinelli R.

J Transl Med. 2011 Jan 4;9:2. doi: 10.1186/1479-5876-9-2.

19.

The cell-adhesion G protein-coupled receptor BAI3 is a high-affinity receptor for C1q-like proteins.

Bolliger MF, Martinelli DC, Südhof TC.

Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2534-9. doi: 10.1073/pnas.1019577108. Epub 2011 Jan 24.

20.

Personalized Therapy of Small Cell Lung Cancer.

Schneider BJ, Kalemkerian GP.

Adv Exp Med Biol. 2016;890:149-74. doi: 10.1007/978-3-319-24932-2_9. Review.

PMID:
26703804

Supplemental Content

Support Center